ICU Medical Inc
NASDAQ:ICUI

Watchlist Manager
ICU Medical Inc Logo
ICU Medical Inc
NASDAQ:ICUI
Watchlist
Price: 168.46 USD -0.23% Market Closed
Market Cap: 4.1B USD
Have any thoughts about
ICU Medical Inc?
Write Note

ICU Medical Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ICU Medical Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
ICU Medical Inc
NASDAQ:ICUI
Depreciation & Amortization
$223.7m
CAGR 3-Years
36%
CAGR 5-Years
24%
CAGR 10-Years
28%
Haemonetics Corp
NYSE:HAE
Depreciation & Amortization
$109.6m
CAGR 3-Years
6%
CAGR 5-Years
0%
CAGR 10-Years
3%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Depreciation & Amortization
$346m
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
10%
Align Technology Inc
NASDAQ:ALGN
Depreciation & Amortization
$139.9m
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
25%
Lantheus Holdings Inc
NASDAQ:LNTH
Depreciation & Amortization
$62.4m
CAGR 3-Years
17%
CAGR 5-Years
36%
CAGR 10-Years
13%
Merit Medical Systems Inc
NASDAQ:MMSI
Depreciation & Amortization
$97.7m
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
11%
No Stocks Found

ICU Medical Inc
Glance View

Market Cap
4.1B USD
Industry
Health Care

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 8,500 full-time employees. The firm provides infusion systems, infusion consumables and critical care products used in hospital, alternate site and home care settings. The firm's product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle free connectors. Its oncology products include ChemoLock and ChemoClave. Its IV consumables include Clave IV Connector Technology, IV Sets, Peripheral IV Catheters and Disinfecting Caps. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services. The company offers blood pressure monitoring system.

ICUI Intrinsic Value
190.76 USD
Undervaluation 12%
Intrinsic Value
Price

See Also

What is ICU Medical Inc's Depreciation & Amortization?
Depreciation & Amortization
223.7m USD

Based on the financial report for Sep 30, 2024, ICU Medical Inc's Depreciation & Amortization amounts to 223.7m USD.

What is ICU Medical Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
28%

Over the last year, the Depreciation & Amortization growth was -2%. The average annual Depreciation & Amortization growth rates for ICU Medical Inc have been 36% over the past three years , 24% over the past five years , and 28% over the past ten years .

Back to Top